{"@context":{"ns0":"http://www.ebi.ac.uk/efo/","rdf":"http://www.w3.org/1999/02/22-rdf-syntax-ns#","owl":"http://www.w3.org/2002/07/owl#","rdfs":"http://www.w3.org/2000/01/rdf-schema#","obo_purl":"http://purl.obolibrary.org/obo/","metadata_def":"http://data.bioontology.org/metadata/def/","metadata":"http://data.bioontology.org/metadata/"},"@graph":[{"@id":"ns0:EFO_0005890","@type":"owl:Class","rdfs:subClassOf":{"@id":"ns0:EFO_0001444"},"rdfs:label":"osteoarthritis biomarker measurement","obo_purl:IAO_0000115":"osteoarthritis biomarkers, such as serum cartilage oligomeric protein (sCOMP) and urinary C-telopeptide of type II collagen (uCTX-II), are used as indicators for osteoarthritis screening and as predictors for therapeutic responses and prognoses in patients","obo_purl:IAO_0000117":"Dani Welter","ns0:gwas_trait":{"@type":"http://www.w3.org/2001/XMLSchema#boolean","@value":"1"},"metadata:def/prefLabel":"osteoarthritis biomarker measurement","metadata:def/mappingLoom":"osteoarthritisbiomarkermeasurement","metadata:def/mappingSameURI":{"@id":"ns0:EFO_0005890"},"metadata:prefixIRI":"efo:EFO_0005890"},{"@id":"ns0:EFO_0007873","rdfs:subClassOf":{"@id":"ns0:EFO_0005890"}},{"@id":"ns0:EFO_0020071","rdfs:subClassOf":{"@id":"ns0:EFO_0005890"}}]}